An investigation on behalf of investors in NASDAQ:STSI shares over potential wrongdoing at Star Scientific, Inc. continues and NASDAQ:STSI stockholders should contact the Shareholders Foundation at firstname.lastname@example.org
San Diego, CA -- (SBWIRE) -- 01/27/2014 -- An investigation on behalf of investor who continuously held NASDAQ:STSI shares since 2007 or earlier, was announced concerning whether certain directors and officers of Star Scientific, Inc. breached their fiduciary duties.
Investors who are current long term stockholders in Star Scientific, Inc. (NASDAQ:STSI) shares, have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns, among other things, whether certain Star Scientific officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
On January 23, 2012, a report was published that alleged that Star Scientific, Inc. misled investors about the involvement of Johns Hopkins University in the clinical testing of the company's retail nutritional supplement anatabine.
On Jan 28, 2013, Star Scientific, Inc. commented on the report from January 23, 2013. Star Scientific, Inc. said that the report contained numerous false and misleading statements regarding the Company's anatabine research and the initial results of the ASAP Human Thyroid Health Study released by Star Scientific on January 7, 2013.
In January and February 2013 Star Scientific, Inc. received subpoenas from the US Attorney's office investigating transactions in Star Scientific’s securities, including related party transactions, dating back to 2006. On March 18, 2013, Star Scientific, Inc. disclosed this investigation to investors, announcing that the Company and its directors had received subpoenas from the US Attorney's office. The Company also announced that it was conducting an internal investigation regarding these transactions.
Shares of Star Scientific, Inc. declined from $4.85 per share in mid-2012 to as low as $0.881 per share on January 24, 2014.
Those who are current long term investors in Star Scientific, Inc. (NASDAQ:STSI) shares, have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)